Richard Aplenc, MD, PhD
Previous Record Next Record

Richard Aplenc, MD, PhD

Richard Aplenc, MD, PhD leads a national trial for recurrent AML. He also explores how the inherited differences that make each person unique determine a patients side effects from cancer treatment. These studies are expected to lead to individualized treatments for each patient based on his or her genetic make-up.